adriamycinol has been researched along with Neutropenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gustafson, DL; Ramirez, D; Weishaar, K; Wittenburg, LA | 1 |
Adkins, D; Butrynski, JE; Chawla, SP; Cranmer, LD; Ganjoo, KN; Kroll, S; Langmuir, VK; Lorente, G; Okuno, SH; Rushing, D | 1 |
1 trial(s) available for adriamycinol and Neutropenia
Article | Year |
---|---|
A phase I study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.
Topics: Abscess; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cellulitis; Disease-Free Survival; Doxorubicin; Drug Eruptions; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphopenia; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Neutropenia; Nitroimidazoles; Phosphoramide Mustards; Sarcoma; Stomatitis; Treatment Outcome; Young Adult | 2011 |
1 other study(ies) available for adriamycinol and Neutropenia
Article | Year |
---|---|
Doxorubicin area under the curve is an important predictor of neutropenia in dogs with naturally occurring cancers.
Topics: Animals; Antibiotics, Antineoplastic; Area Under Curve; Chromatography, High Pressure Liquid; Colorado; Dog Diseases; Dogs; Doxorubicin; Female; Linear Models; Male; Neoplasms; Neutropenia; Schools, Veterinary | 2019 |